218 related articles for article (PubMed ID: 16210611)
1. Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing/remitting form.
Mujtaba MG; Flowers LO; Patel CB; Patel RA; Haider MI; Johnson HM
J Immunol; 2005 Oct; 175(8):5077-86. PubMed ID: 16210611
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function.
Flowers LO; Johnson HM; Mujtaba MG; Ellis MR; Haider SM; Subramaniam PS
J Immunol; 2004 Jun; 172(12):7510-8. PubMed ID: 15187130
[TBL] [Abstract][Full Text] [Related]
3. Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist.
Waiboci LW; Ahmed CM; Mujtaba MG; Flowers LO; Martin JP; Haider MI; Johnson HM
J Immunol; 2007 Apr; 178(8):5058-68. PubMed ID: 17404288
[TBL] [Abstract][Full Text] [Related]
4. A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells.
Flowers LO; Subramaniam PS; Johnson HM
Oncogene; 2005 Mar; 24(12):2114-20. PubMed ID: 15688010
[TBL] [Abstract][Full Text] [Related]
5. Oral feeding of interferon tau can prevent the acute and chronic relapsing forms of experimental allergic encephalomyelitis.
Soos JM; Mujtaba MG; Subramaniam PS; Streit WJ; Johnson HM
J Neuroimmunol; 1997 May; 75(1-2):43-50. PubMed ID: 9143236
[TBL] [Abstract][Full Text] [Related]
6. IFN-tau suppresses both the autoreactive humoral and cellular immune responses and induces stable remission in mice with chronic experimental allergic encephalomyelitis.
Mujtaba MG; Streit WJ; Johnson HM
Cell Immunol; 1998 Jun; 186(2):94-102. PubMed ID: 9665751
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of suppressors of cytokine signaling-1 and -3 and related cytokines in central nervous system during remitting versus non-remitting forms of experimental autoimmune encephalomyelitis.
Stark JL; Cross AH
Int Immunol; 2006 Feb; 18(2):347-53. PubMed ID: 16373362
[TBL] [Abstract][Full Text] [Related]
8. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
Takács K; Chandler P; Altmann DM
Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
[TBL] [Abstract][Full Text] [Related]
9. The kinase inhibitory region of SOCS-1 is sufficient to inhibit T-helper 17 and other immune functions in experimental allergic encephalomyelitis.
Jager LD; Dabelic R; Waiboci LW; Lau K; Haider MS; Ahmed CM; Larkin J; David S; Johnson HM
J Neuroimmunol; 2011 Mar; 232(1-2):108-18. PubMed ID: 21131060
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signaling 1 inhibits cytokine induction of CD40 expression in macrophages.
Wesemann DR; Dong Y; O'Keefe GM; Nguyen VT; Benveniste EN
J Immunol; 2002 Sep; 169(5):2354-60. PubMed ID: 12193701
[TBL] [Abstract][Full Text] [Related]
11. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M
J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735
[TBL] [Abstract][Full Text] [Related]
12. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
[TBL] [Abstract][Full Text] [Related]
13. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of SOCS1 in macrophages in relapsing-remitting and chronic EAE and its role in disease severity.
Berard JL; Kerr BJ; Johnson HM; David S
Glia; 2010 Nov; 58(15):1816-26. PubMed ID: 20645407
[TBL] [Abstract][Full Text] [Related]
15. Substrain differences reveal novel disease-modifying gene candidates that alter the clinical course of a rodent model of multiple sclerosis.
deLuca LE; Pikor NB; O'Leary J; Galicia-Rosas G; Ward LA; Defreitas D; Finlay TM; Ousman SS; Osborne LR; Gommerman JL
J Immunol; 2010 Mar; 184(6):3174-85. PubMed ID: 20173032
[TBL] [Abstract][Full Text] [Related]
16. The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents.
Dinter H; Tse J; Halks-Miller M; Asarnow D; Onuffer J; Faulds D; Mitrovic B; Kirsch G; Laurent H; Esperling P; Seidelmann D; Ottow E; Schneider H; Tuohy VK; Wachtel H; Perez HD
J Neuroimmunol; 2000 Aug; 108(1-2):136-46. PubMed ID: 10900347
[TBL] [Abstract][Full Text] [Related]
17. Suppression of ongoing experimental allergic encephalomyelitis (EAE) in Lewis rats: synergistic effects of myelin basic protein (MBP) peptide 68-86 and IL-4.
Xu LY; Huang YM; Yang JS; Van Der Meide PH; Link H; Xiao BG
Clin Exp Immunol; 2000 Jun; 120(3):526-31. PubMed ID: 10844533
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma produced by encephalitogenic cells induces suppressors of cytokine signaling in primary murine astrocytes.
Stark JL; Lyons JA; Cross AH
J Neuroimmunol; 2004 Jun; 151(1-2):195-200. PubMed ID: 15145618
[TBL] [Abstract][Full Text] [Related]
19. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis.
Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H
J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
